JustinMatthewLongMDPhD

Neurology • Saint Louis, MO

Neurodegenerative, Dementia & Geriatrics

Assistant Professor at Washington University

Join to view full profile

Dr. Long is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Long's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-362-1408

Fax+1 314-286-1985

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Dementia, 2018 - 2020
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2014 - 2018
Indiana University School of MedicineClass of 2014
Indiana UniversityPhD, Medical Neuroscience, 2007 - 2013
Indiana UniversityBS, Biology, Highest Academic Distinction, General Honor Notation, 2001 - 2004

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2017 - 2025
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

1529 citations
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Justin M. Long, David M. Holtzman
Cell. 2019-10-03
245 citations
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Yang Shi, Melissa Manis, Justin M. Long, Kairuo Wang, Patrick Sullivan
The Journal of Experimental Medicine. 2019-11-04
97 citations
Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease.
Justin M. Long, Bryan Maloney, Jack T. Rogers, Debomoy K. Lahiri
Molecular Psychiatry. 2019-03-01

Journal Articles

Novel Upregulation of Amyloid-Β Precursor Protein (APP) by microRNA-346 via Targeting of APP mRNA 5′-Untranslated Region: Implications in Alzheimer’s Disease
Justin Long, MD, Nature

Press Mentions

COVID-19 Closes Labs, Slows Data Collection—The Impact on the Neurology Research PipelineJuly 11th, 2020
Aducanumab About-Face: Experts Weigh InJuly 11th, 2020
A Discontinued Alzheimer’s Trial Comes Alive Again. Will Biogen’s Aducanumab Survive the FDA Review?July 11th, 2020